Table 1.
Patients implanted due to profound hearing loss caused by otosclerosis.
| Case | Gender | Age (yrs) | CI usage time (yrs) | Implanted ear | Device | Configuration/Strategy | Electrode shape | FNS | Electrodes causing FNS |
|---|---|---|---|---|---|---|---|---|---|
| 1 | M | 84 | 10 | AS | Ineraid® | MP/CIS | Straight | No | - |
| 2 | M | 77 | 11 | AD | Ineraid® | MP/CIS | Straight | No | - |
| 3 | F | 69 | 4 | AS | Nucleus® 24M | MP/ACE | Straight | Yes | 15–17 |
| 4 | F | 73 | 4 | AS | Nucleus® 24M | MP/ACE | Straight | No | - |
| 5 | F | 73 | 17 | AD | Nucleus® 22 | BP/SPEAK | Straight | No | - |
| 6 | M | 80 | 19 | AD | Nucleus® 22 | BP/SPEAK | Straight | Yes | 12,16 |
| 7 | F | 74 | 8 | AS | HF® II w/p | MP/HiRes | Perimodiolar | No | - |
| 8 | F | 74 | 8 | AD | HF® II w/p | MP/HiRes | Perimodiolar | No | - |
| 9 | M | 83 | 23 | AS | Nucleus® 22 | BP/SPEAK | Straight | Yes | 15–17 |
| 10 | M | 76 | 8 | AS | Nucleus® 24R | MP/ACE | Perimodiolar | No | - |
| 11 | M | 89 | 17 | AS | Nucleus® 22 | BP/SPEAK | Straight | Yes | 14–18 |
| 12 | M | 87 | 3 | AD | Nucleus® 22 | BP/SPEAK | Straight | No | - |
| 13 | M | 74 | 2 | AS | Nucleus® 22 | BP/SPEAK | Straight | No | - |
M: Male; F: Female; AD: Right; AS: Left; HF® II w/p: Hi Focus II with positioner; BP: Bipolar; MP: Monopolar.